Total Payments
$12,400
2024 Payments
$1,129
Companies
37
Transactions
240
Medicare Patients
1,474
Medicare Billing
$207,710
Payment Breakdown by Category
Other$7,767 (62.6%)
Food & Beverage$4,610 (37.2%)
Education$22.62 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,610 | 232 | 37.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,225 | 3 | 34.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $2,400 | 1 | 19.4% |
| Honoraria | $600.00 | 1 | 4.8% |
| Long term medical supply or device loan | $542.22 | 2 | 4.4% |
| Education | $22.62 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,880 | 26 | $0 (2024) |
| Concordia Pharmaceuticals Inc. | $2,350 | 10 | $0 (2019) |
| Wilson Cook Medical Incorporated | $2,225 | 1 | $0 (2021) |
| ABBVIE INC. | $1,482 | 77 | $0 (2024) |
| ParaPRO, LLC | $600.00 | 1 | $0 (2019) |
| PENTAX of America, Inc. | $552.35 | 3 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $291.78 | 17 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $251.70 | 13 | $0 (2023) |
| PFIZER INC. | $234.87 | 13 | $0 (2024) |
| Janssen Biotech, Inc. | $182.53 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,129 | 31 | PENTAX of America, Inc. ($552.35) |
| 2023 | $543.74 | 27 | AbbVie Inc. ($177.79) |
| 2022 | $91.29 | 4 | ABBVIE INC. ($91.29) |
| 2021 | $2,584 | 19 | Wilson Cook Medical Incorporated ($2,225) |
| 2020 | $2,596 | 7 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($2,491) |
| 2019 | $3,348 | 38 | Concordia Pharmaceuticals Inc. ($2,265) |
| 2018 | $1,705 | 93 | AbbVie, Inc. ($563.60) |
| 2017 | $404.28 | 21 | Covidien LP ($79.89) |
All Payment Transactions
240 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.03 | General |
| 10/18/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/24/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.52 | General |
| 08/15/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/09/2024 | PENTAX of America, Inc. | INSPIRA (Device), PENTAX Medical, PENTAX Medical | Food and Beverage | Cash or cash equivalent | $10.13 | General |
| Category: Gastroenterology | ||||||
| 07/17/2024 | PENTAX of America, Inc. | VIDEO COLONOSCOPE (Device) | Long term medical supply or device loan | In-kind items and services | $240.40 | General |
| Category: Gastroenterology | ||||||
| 07/16/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Immunology | ||||||
| 07/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Immunology | ||||||
| 07/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/20/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Immunology | ||||||
| 06/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.93 | General |
| 06/11/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Immunology | ||||||
| 05/29/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: IMMUNOLOGY | ||||||
| 05/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Immunology | ||||||
| 05/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Gastroenterology | ||||||
| 04/29/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Immunology | ||||||
| 04/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $34.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: IMMUNOLOGY | ||||||
| 03/20/2024 | PENTAX of America, Inc. | VIDEO COLONOSCOPE (Device) | Long term medical supply or device loan | In-kind items and services | $301.82 | General |
| Category: Gastroenterology | ||||||
| 02/29/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 02/26/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 180 | 190 | $46,920 | $17,511 |
| 2022 | 10 | 341 | 427 | $229,922 | $49,631 |
| 2021 | 12 | 502 | 647 | $290,724 | $74,734 |
| 2020 | 11 | 451 | 620 | $221,704 | $65,834 |
Total Patients
1,474
Total Services
1,884
Medicare Billing
$207,710
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 11 | 11 | $5,644 | $3,651 | 64.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 24 | 24 | $13,000 | $3,610 | 27.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $4,800 | $2,274 | 47.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 21 | $4,692 | $2,087 | 44.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 12 | 13 | $4,780 | $2,037 | 42.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $3,534 | $1,890 | 53.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 17 | 18 | $7,750 | $922.21 | 11.9% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 2023 | 18 | 20 | $1,700 | $900.55 | 53.0% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 33 | 34 | $1,020 | $141.06 | 13.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 60 | 94 | $74,707 | $13,733 | 18.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 75 | 111 | $45,524 | $11,382 | 25.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 29 | 29 | $12,320 | $4,775 | 38.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 25 | 25 | $20,900 | $4,134 | 19.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 56 | $11,888 | $3,743 | 31.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 23 | 23 | $22,402 | $3,466 | 15.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $18,077 | $3,465 | 19.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 16 | 22 | $4,840 | $1,889 | 39.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 24 | 24 | $14,310 | $1,682 | 11.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 17 | 17 | $4,954 | $1,362 | 27.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 101 | 178 | $52,758 | $18,581 | 35.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 66 | 110 | $76,424 | $16,908 | 22.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 53 | 53 | $49,068 | $9,590 | 19.5% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 37 | 37 | $28,120 | $5,189 | 18.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 30 | 30 | $12,600 | $4,951 | 39.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 29 | 29 | $12,274 | $3,444 | 28.1% |
About Dr. Marvin Singh, M.D
Dr. Marvin Singh, M.D is a Gastroenterology healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1306968417.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marvin Singh, M.D has received a total of $12,400 in payments from pharmaceutical and medical device companies, with $1,129 received in 2024. These payments were reported across 240 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($4,610).
As a Medicare-enrolled provider, Singh has provided services to 1,474 Medicare beneficiaries, totaling 1,884 services with total Medicare billing of $207,710. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Rochester, NY
- Active Since 04/06/2007
- Last Updated 03/07/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1306968417
Products in Payments
- XIFAXAN (Drug) $2,865
- Hemospray (Device) $2,225
- Donnatal (Drug) $2,092
- Esomeprazole Strontium DR Capsule 49.3mg (Drug) $600.00
- VIDEO COLONOSCOPE (Device) $542.22
- Humira (Biological) $320.43
- HUMIRA (Biological) $290.17
- DONNATAL (Drug) $258.07
- Mavyret (Drug) $235.39
- XELJANZ (Drug) $209.30
- STELARA (Biological) $198.57
- Sucraid (Drug) $166.79
- CLENPIQ (Drug) $158.91
- RINVOQ (Biological) $148.40
- Creon (Drug) $117.82
- LINZESS (Drug) $109.49
- DUPIXENT (Biological) $100.30
- SKYRIZI (Biological) $90.32
- ENTYVIO (Biological) $84.44
- OMVOH (Drug) $84.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Rochester
Edward Loftus, M.d, M.D
Gastroenterology — Payments: $379,661
Gastroenterology $379,661
Christopher Gostout, M.d, M.D
Gastroenterology — Payments: $317,848
Gastroenterology $317,848
Vivek Kaul, Md, MD
Gastroenterology — Payments: $307,068
Gastroenterology $307,068
Todd Baron, M.d, M.D
Gastroenterology — Payments: $296,029
Gastroenterology $296,029
Russell Wiesner, M.d, M.D
Gastroenterology — Payments: $231,350
Gastroenterology $231,350
Joseph Murray, M.d, M.D
Gastroenterology — Payments: $200,483
Gastroenterology $200,483